Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Other Non Operating Income of -$494000.0 for Q1 2026, down 2158.33% year-over-year from $24000.0 in Q1 2025, and down 1048.84% quarter-over-quarter from -$43000.0 in Q4 2025.
Analysis
Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$494000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 2158.33% year-over-year to -$494000.0; the TTM figure through Mar 2026 stood at -$4.7 million (down 42.86% YoY), while the FY2025 annual figure was -$4.2 million, down 30.28% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$494000.0, down from -$43000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.4 million in Q4 2023, with the low at -$4.1 million in Q2 2025.
- The 5-year median for Other Non Operating Income is -$43000.0 (2025), against an average of -$464600.0.
- Peak annual rise in Other Non Operating Income reached 429.35% in 2022, while the deepest fall reached 6766.67% in 2022.
- Maravai Lifesciences Holdings' Other Non Operating Income stood at $1.1 million in 2022, then jumped by 30.26% to $1.4 million in 2023, then sank by 157.94% to -$803000.0 in 2024, then soared by 94.65% to -$43000.0 in 2025, then tumbled by 1048.84% to -$494000.0 in 2026.
- Business Quant data shows MRVI's Other Non Operating Income at -$494000.0 in Q1 2026, -$43000.0 in Q4 2025, and -$71000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.01 Mn |
| Mar 31, 2026 | -494,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -4.06 Mn |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | -803,000.00 |
| Sep 30, 2024 | 72,000.00 |
| Jun 30, 2024 | -2.56 Mn |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 66,000.00 |
| Jun 30, 2023 | -1.62 Mn |
| Mar 31, 2023 | 168,000.00 |
| Dec 31, 2022 | 914,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | -1.28 Mn |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | 201,000.00 |
| Sep 30, 2021 | 78,000.00 |